RMgmDB - Rodent Malaria genetically modified Parasites

Back to search results

Summary

RMgm-5456
Malaria parasiteP. berghei
Genotype
TaggedGene model (rodent): PBANKA_0504100; Gene model (P.falciparum): PF3D7_1019900; Gene product: autophagy-related protein 8 (ATG8)
Name tag: 3XHA–mCherry
Phenotype Asexual bloodstage;
Last modified: 23 April 2024, 22:05
  *RMgm-5456
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene tagging
Reference (PubMed-PMID number) Reference 1 (PMID number) : 37910326
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherMishra A, Mishra S
Name Group/DepartmentDivision of Molecular Microbiology and Immunology
Name InstituteCSIR-Central Drug Research Institute
CityLucknow
CountryIndia
Name of the mutant parasite
RMgm numberRMgm-5456
Principal nameAtg8-3XHA-mCherry
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageTo check if Plasmodium Atg4 retains Atg8 processing activity despite its exposed glycine, we investigated the importance of cysteine protease for Atg8 conjugation. Atg8 was endogenously tagged with 3XHA–mCherry at the C-terminus to mask its exposed glycine.
Atg8-3XHA-mCherry schizont cultures were treated with the cysteine protease inhibitor E64 to evaluate cysteine protease activity. The treated and untreated schizonts were fixed and analyzed by IFA using anti-Atg8 and anti-mCherry antibodies. Without an inhibitor, mCherry was cleaved, as confirmed by independent signals of Atg8 and mCherry that did not colocalize. However, E64-treated Atg8-3XHA-mCherry schizonts showed overlapping staining patterns. The treated Atg8-3XHAmCherry and WT schizonts also failed to properly segregate their nuclei and were found to be arrested during schizogony, which was due to the general inhibition of parasites by E64. Atg8 conjugation was not affected in the arrested WT parasites, suggesting that parasites could conjugate Atg8 with exposed glycine.
Gametocyte/GameteNot tested
Fertilization and ookineteNot tested
OocystNot tested
SporozoiteNot tested
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
The mutant expresses a C-terminal 3XHA–mCherry-tagged version of ATG8.
To check if Plasmodium Atg4 retains Atg8 processing activity despite its exposed glycine, we investigated the importance of cysteine protease for Atg8 conjugation. Atg8 was endogenously tagged with 3XHA–mCherry at the C-terminus to mask its exposed glycine.

Protein (function)
Autophagy (macroautophagy) is a catabolic process conserved from yeast to mammals. During macroautophagy, the Atg8 protein is conjugated to phosphatidylethanolamine (PE) in autophagic membranes. Atg8 localizes on isolated membranes and autophagosomes and has been considered a marker of the induction and progression of autophagy. The presence of Atg8 on the autophagosome is related to its many roles, such as cargo selection, fusion, and membrane tethering and expansion. In yeast, Atg8 is synthesized with a terminal peptide, which is immediately cleaved by the cysteine protease autophagy-related protein 4 (Atg4), revealing a glycine at the C-terminus, which then acts as a substrate in the ubiquitin-like conjugation reaction mediated by Atg7 (E1-activating enzyme) and Atg3 (E2 conjugating enzyme), which mediates its conjugation to PE on the autophagosome membrane. The conjugation of Atg8 to the membrane is reversible, and Atg8 is deconjugated from the outer surface upon autophagosome closure. Deconjugation is important for replenishing Atg8 for further autophagosome formation Two different classes of cysteine proteases have been found to play a role in deconjugatio: one is Atg4 of the C4 cysteine protease family, which cleaves at the C-terminus of the Atg8–PE bond, and the other is ovarian tumor unit (Otu) of the DUB family, which irreversibly inactivates Atg8 by cleaving at the N-terminus of the Atg8–PE bond. In Apicomplexan parasites, two cysteine proteases, Atg4 and ovarian tumor unit (Otu), have been identified to delipidate Atg8 to release this protein from membranes. Here, we investigated the role of cysteine proteases in Atg8 conjugation and deconjugation and found that the Plasmodium parasite consists of both activities.

From the paper:
'We successfully disrupted the genes individually; however, simultaneously, they were refractory to deletion and essential for parasite survival. Mutants lacking Atg4 and Otu showed normal blood and mosquito stage development. All mice infected with Otu KO sporozoites became patent; however, Atg4 KO sporozoites either failed to establish blood infection or showed delayed patency. Through in vitro and in vivo analysis, we found that Atg4 KO sporozoites invade and normally develop into early liver stages. However, nuclear and organelle differentiation was severely hampered during late stages and failed to mature into hepatic merozoites. We found a higher level of Atg8 in Atg4 KO parasites, and the deconjugation of Atg8 was hampered. We confirmed Otu localization on the apicoplast; however, parasites lacking Otu showed no visible developmental defects. Our data suggest that Atg4 is the primary deconjugating enzyme and that Otu cannot replace its function completely because it cleaves the peptide bond at the N-terminal side of glycine, thereby irreversibly inactivating Atg8 during its recycling' .
Attempts to generate and select Atg4/Otu double knockout parasites were unsuccessful.

Phenotype
To check if Plasmodium Atg4 retains Atg8 processing activity despite its exposed glycine, we investigated the importance of cysteine protease for Atg8 conjugation. Atg8 was endogenously tagged with 3XHA–mCherry at the C-terminus to mask its exposed glycine.
Atg8-3XHA-mCherry schizont cultures were treated with the cysteine protease inhibitor E64 to evaluate cysteine protease activity. The treated and untreated schizonts were fixed and analyzed by IFA using anti-Atg8 and anti-mCherry antibodies. Without an inhibitor, mCherry was cleaved, as confirmed by independent signals of Atg8 and mCherry that did not colocalize. However, E64-treated Atg8-3XHA-mCherry schizonts showed overlapping staining patterns. The treated Atg8-3XHAmCherry and WT schizonts also failed to properly segregate their nuclei and were found to be arrested during schizogony, which was due to the general inhibition of parasites by E64. Atg8 conjugation was not affected in the arrested WT parasites, suggesting that parasites could conjugate Atg8 with exposed glycine.
Furthermore, the cleavage of ATG8 was ascertained by western blot analysis of Atg8-3XHA-mCherry schizonts using anti-ATG8 and anti-HA antibodies. We found processing of 3XHA-mCherry in untreated samples, while no processing was observed in E64-treated parasites. These results indicate that in the presence of an E64 inhibitor, cysteine proteases failed to process the 3XHA-mCherry tag from the C-terminus of Atg8 and subsequently failed to conjugate on the apicoplast membrane.

See also RMgm-1475 and RMgm-1953 for unsuccessful attempts to knock-out the Atg8 gene, indicating an essential function of ATG8 for growth/multiplication of asexual blood stages.

Additional information
To functionally characterize the role of Atg4 (PBANKA_1025400) and Otu (PBANKA_0515350) in the Plasmodium berghei life cycle, these genes were disrupted using double-crossover homologous recombination (see RMgm-5457 and RMgm-5458). In addition, attempts were preformed to generate and select Atg4/Otu double knockout parasites. These attempts were unsuccessful (see RMgm-5459).
The following was found:
Mutants lacking Atg4 (RMgm-5457) and Otu (RMgm-5458) showed normal blood and mosquito stage development. All mice infected with Otu KO sporozoites became patent; however, Atg4 KO sporozoites either failed to establish blood infection or showed delayed patency. Through in vitro and in vivo analysis, we found that Atg4 KO sporozoites invade and normally develop into early liver stages. However, nuclear and organelle differentiation was severely hampered during late stages and failed to mature into hepatic merozoites. We found a higher level of Atg8 in Atg4 KO parasites, and the deconjugation of Atg8 was hampered. We confirmed Otu localization on the apicoplast (see mutant RMgm-5460); however, parasites lacking Otu showed no visible developmental defects. Our data suggest that Atg4 is the primary deconjugating enzyme and that Otu cannot replace its function completely because it cleaves the peptide bond at the N-terminal side of glycine, thereby irreversibly inactivating Atg8 during its recycling' .
Evidence is presented that:
- Cysteine proteases are essential for Atg8 processing
- Atg4 is a deconjugating enzyme, and Atg4 KO parasites failed to deconjugate Atg8
- Atg4 is critical for late liver stage development
- Atg4 KO parasites show impaired (liver-stage) merozoite formation
- Atg4 is dispensable for exocytosis of micronemes
- Atg8‑PE deconjugation is essential for organelle biogenesis during liver stage development
- Atg4/Otu double gene deletion is lethal for blood‑stage propagation

Other mutants


  Tagged: Mutant parasite with a tagged gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0504100
Gene Model P. falciparum ortholog PF3D7_1019900
Gene productautophagy-related protein 8
Gene product: Alternative nameATG8
Details of the genetic modification
Name of the tag3XHA–mCherry
Details of taggingC-terminal
Additional remarks: tagging
Commercial source of tag-antibodies
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationFor the endogenous tagging of Atg8 (PBANKA_0504100) to generate Atg8-3XHAmCherry transgenic parasites, two fragments, F1 (630 bp) and F2 (547 bp), were amplified using primers 1560/1561 and 1562/1563, respectively, and cloned sequentially into the pBC–3XHA–mCherry–hDHFR vector at XhoI/BglII and NotI/AscI, respectively. The plasmid was linearized using XhoI/AscI and transfected into P. berghei ANKA schizonts.

Additional information on mutants generated in this study:
To generate Atg4 (PBANKA_1025400) knockout parasites, double-crossover homologous recombination was used. For this, two fragments, F1 (967 bp) and F2 (556 bp), were amplified using primer sets 1655/1656 and 1333/1355. from the 5′ and 3′ UTRs of the gene, respectively, and were sequentially cloned into the pBC–GFP–hDHFR vector at XhoI/ClaI and NotI/AscI, respectively. The plasmid was linearized using XhoI/AscI and transfected into P. berghei ANKA schizonts.

For the generation of Otu (PBANKA_0515350) knockout parasites, two fragments, F1 (591 bp) and F2 (546 bp), were amplified using primer sets 1964/1965 and 1966/1967 from the 5′ and 3′ UTRs, respectively, and sequentially cloned into the pBC–mCherry–TgDHFR vector at KpnI/ClaI and NotI/AscI, respectively. The plasmid was linearized using KpnI/AscI and transfected into P. berghei ANKA schizonts.

For the generation of Atg4/Otu double knockout parasites, the linearized targeting cassette of Atg4 with GFP reporter and hDHFR selection marker was transfected into the purified schizonts of Otu KO parasites with mCherry reporter and TgDHFR selection marker. The transfected parasites were selected by the subcutaneous injection of WR drug (Sigma-Aldrich, SML2976) for 3 consecutive days.
In the second approach, Otu–mCherry–TgDHFR and Atg4–GFP–hDHFR linearized cassettes were cotransfected into P. berghei ANKA schizonts. The transfected parasites were selected by the oral administration of pyrimethamine.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6